Hypersensitivity Cross-Reactivity for Ultrasound-Enhancing Agents and COVID-19 Vaccines - 02/05/22
The study was approved by the Institutional Review Board of Oregon Health and Science University. |
|
Conflicts of Interest: None. |
|
Dr. Lindner is supported by grants R01-HL078610, R01-HL130046, and P51-OD011092 from the National Institutes of Health (NIH), Bethesda, MD; and grant 18-18HCFBP_2-0009 from NASA. |
Vol 35 - N° 5
P. 523-525 - mai 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.